Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHILPA MEDICARE Gains 6%; BSE HEALTHCARE Index Up 0.2%
Thu, 21 Nov 15:22

SHILPA MEDICARE Gains 6%; BSE HEALTHCARE Index Up 0.2%Image source: Sakorn BernardaSv/www.istockphoto.com

SHILPA MEDICARE share price has zoomed 6% and is presently trading at Rs 935.0.

Meanwhile, the BSE HEALTHCARE index is at 42,466.2 (up 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (up 3.4%) and KIMS (up 3.1%).

SUN PHARMA ADV. RES. (down 3.0%) and GSK Pharma (down 2.7%) are among the top losers today.

Over the last one year, SHILPA MEDICARE has moved up from Rs 368.7 to Rs 935.0, registering a gain of Rs 566.3 (up 153.6%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,583.1 to 42,466.2, registering a gain of 43.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 159.9%), SUVEN PHARMACEUTICALS (up 114.6%) and FORTIS HEALTHCARE (up 88.5%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 77,162.3 (down 0.5%).

The top losers among the BSE Sensex today are MUNDRA PORT & SEZ (down 13.6%) and NTPC (down 2.7%). The most traded stocks in the BSE Sensex are Tata Steel and MUNDRA PORT & SEZ.

In the meantime, NSE Nifty is at 23,349.4 (down 0.7%). Adani Enterprises and MUNDRA PORT & SEZ are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,655.2 to 77,162.3, registering a gain of 11,507.1 points (up 17.5%).

SHILPA MEDICARE Financial Update...

SHILPA MEDICARE net profit grew 426.7% YoY to Rs 183 million for the quarter ended September 2024, compared to a profit of Rs 35 million a year ago. Net sales rose 9.8% to Rs 3,438 million during the period as against Rs 3,130 million in July-September 2023.

For the year ended March 2024, SHILPA MEDICARE reported 203.4% increase in net profit to Rs 320 million compared to net loss of Rs 309 million during FY23. Revenue of the company grew 9.7% to Rs 11,516 million during FY24.

The current Price to earnings ratio of SHILPA MEDICARE, based on rolling 12 month earnings, stands at 137.9.


Equitymaster requests your view! Post a comment on "SHILPA MEDICARE Gains 6%; BSE HEALTHCARE Index Up 0.2%". Click here!